Novartis Signs Pact to Help Produce Pfizer-BioNTech Vaccine
Vials of the Pfizer BioNtech Covid-19 vaccine
Photographer: Mauricio Palos/BloombergThis article is for subscribers only.
Novartis AG, the Swiss drugmaker, agreed to help produce the Covid-19 vaccine developed by Pfizer Inc. and BioNTech SE, boosting efforts to meet demand amid concerns about supply constraints.
Production is due to begin in the second quarter, with estimated delivery in the third quarter, according to a statement from the company on Friday. The pharma giant will rely on manufacturing facilities at a site in Stein, Switzerland.